WP1122
WP-1122 (WP 1122) is a candidate drug to treat SARS-COV-2 (COVID-19) .2-DG completely prevented SARS-CoV–2 replication in Caco–2 cells. Glycolysis is a process by which cells convert glucose into energy and infected (host) cells are induced by viruses to dramatically increase their dependence on glycolysis. WP1122 is a prodrug of 2-DG whereby chemical elements are added to 2-DG to improve its delivery in vivo.
Product Specifications
CAS Number
1204310-73-5
Purity
>98%
Smiles
O1C (C[C@H] ([C@@H] ([C@H]1COC (C) =O) O) OC (C) =O) O
Molecular Formula
C10H16O7
Molecular Weight
248.229844093323
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
S1013-87J1-FITC 100 µL
SIRP alpha (SIRPA, SIRPa, CD172a, Tyrosine-protein Phosphatase Non-receptor Type Substrate 1, SHP Substrate 1, SHPS-1) (FITC) Discontinued. See S1013-87H1
Sign In for Pricing
View Details 